Karo Pharma Grabs J&J’s Pevaryl Brand In Europe
Karo has picked up the full European rights to the Pevaryl antifungal brand from Johnson & Johnson.
You may also be interested in...
Consumer health first-quarter results round-up featuring Karo Pharma, Boiron and Ipsen.
The latest European consumer health business news: France's Mayoly Spindler acquires Italian supplements specialist Biohealth; UK-based Flarin gets funding to expand at home and abroad; and Sweden's Karo plots further M&A in 2021.
Generics giant Teva has divested a portfolio of OTC brands marketed in the Nordics to Sweden's Karo, which has been distributing the products in the region for the past 18 months.